sexta-feira, 24 de julho de 2015

Effect of prone positioning during mechanical ventilation

Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: a systematic review and meta-analysis

  1. Claude Guérin, MD PhD
    1. Abstract

      Background: Mechanical ventilation in the prone position is used to improve oxygenation and to mitigate the harmful effects of mechanical ventilation in patients with acute respiratory distress syndrome (ARDS). We sought to determine the effect of prone positioning on mortality among patients with ARDS receiving protective lung ventilation.
      Methods: We searched electronic databases and conference proceedings to identify relevant randomized controlled trials (RCTs) published through August 2013. We included RCTs that compared prone and supine positioning during mechanical ventilation in patients with ARDS. We assessed risk of bias and obtained data on all-cause mortality (determined at hospital discharge or, if unavailable, after longest follow-up period). We used random-effects models for the pooled analyses.
      Results: We identified 11 RCTs (n = 2341) that met our inclusion criteria. In the 6 trials (n = 1016) that used a protective ventilation strategy with reduced tidal volumes, prone positioning significantly reduced mortality (risk ratio 0.74, 95% confidence interval 0.59–0.95; I2 = 29%) compared with supine positioning. The mortality benefit remained in several sensitivity analyses. The overall quality of evidence was high. The risk of bias was low in all of the trials except one, which was small. Statistical heterogeneity was low (I2 < 50%) for most of the clinical and physiologic outcomes.
      Interpretation: Our analysis of high-quality evidence showed that use of the prone position during mechanical ventilation improved survival among patients with ARDS who received protective lung ventilation.
      Acute respiratory distress syndrome (ARDS) is a fulminant disease characterized by impaired oxygenation, pulmonary congestion and decreased lung compliance following a direct pulmonary insult, such as aspiration or pneumonia, or a systemic injury, such as sepsis or trauma. In many patients with ARDS, mechanical ventilation can further injure damaged lungs,13 leading to long-term morbidity and mortality. Although minimizing tidal volumes4 and optimizing positive end-expiratory pressure (PEEP)5 may reduce lung injury, mortality associated with ARDS remains high.6,7
      Placing patients in the prone position for a portion of time each day during mechanical ventilation, first suggested in 1974,8 is sometimes used as a protective lung strategy in patients with ARDS.9,10 Alveolar distension varies regionally because of gravity and anatomic relationships with the chest wall and heart. In the prone position, the volume of lung collapsed under its own weight and that of the heart is decreased relative to the supine position.10,11 Because pulmonary perfusion is preserved in both the ventral and dorsal lung regions, ventilation–perfusion matching is improved in the prone position.12 More homogenous dispersion of tidal volume in the prone position may minimize alveolar stretch and strain.10 Improvements in oxygenation may reduce the risk of death from hypoxia.13,14
      Early randomized controlled trials (RCTs) of prone positioning did not show reductions in mortality.15,16 However, these trials included patients with mild ARDS, the duration of prone positioning each day was short, and protective lung ventilation (low tidal volumes) was not used. A subsequent meta-analysis suggested that prone positioning reduces mortality among patients with severe hypoxemia.13 Because of the availability of new data,17 we undertook a systematic review and meta-analysis, in collaboration with all of the primary investigators, to determine whether a strategy incorporating the prone position for a portion of each day, compared with supine position alone, decreases mortality among patients with ARDS receiving protective lung ventilation.

      Methods

      Literature search

      We conducted a systematic review using a previously described protocol with prespecified selection criteria, outcome measures and analysis plan.13Amendments to the protocol for the current review are described in Appendix 1 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.140081/-/DC1). We systematically searched multiple sources to identify RCTs that compared prone positioning with supine positioning during mechanical ventilation in patients with ARDS. To identify relevant trials published since the earlier systematic review,13 we searched the electronic databases MEDLINE, Embase and CENTRAL (the Cochrane Central Register of Controlled Trials) for articles published from June 2009 to August 2013. We also searched the bibliographies of included studies and review articles, as well as the conference proceedings of the American Thoracic Society (1994–2013), the Society of Critical Care Medicine (1994–2013) and the European Society of Intensive Care Medicine (1994–2013). Finally, we searched the ClinicalTrials.gov registry and the Current Controlled Trials database for unpublished and ongoing trials. No language restrictions were applied. Details of our search strategy are described in Appendix 2 (available atwww.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.140081/-/DC1).

      Study selection

      Three of us (S.S., J.O.F. and M.S.), who were not blinded to the study authors or results, independently evaluated the studies for inclusion and resolved differences through consensus.
      We included RCTs and quasi-randomized trials (e.g., trials allocating patients in alternating fashion or by hospital registry number) if they met the following criteria: they enrolled adults or postneonatal children with ARDS supported by mechanical ventilation; they used prone positioning in the experimental group and supine positioning alone in the control group; and they reported any of the primary or secondary outcomes described in the next section. We included trials that used either the older18 or more recent19 definition of ARDS. For trials that enrolled patients with other forms of hypoxemic respiratory failure, we asked the primary investigators to supply mortality data for patients who had ARDS at the time of enrolment.
      We excluded crossover trials. We also excluded physiologic studies lasting 48 hours or less, reasoning that a brief intervention period would not affect clinical outcomes.

      Data extraction and quality assessment

      The 3 of us involved in selecting the studies also independently abstracted data on study methods, details of prone positioning and mechanical ventilation, and study outcomes. Disagreements were resolved through consensus.
      The primary outcome was all-cause mortality. For each study, mortality was determined at hospital discharge or, if not available, the longest duration of follow-up. For the primary analysis, we included only trials in which all patients received protective lung ventilation (defined as tidal volume < 8 mL/kg of predicted body weight),4 because we felt studies that did not use protective ventilation might bias results to the null20,21 and would be less relevant to current clinical practice. Studies that did not mandate protective lung ventilation were included in the analyses of secondary outcomes.
      Secondary outcomes included change in oxygenation and adverse events (ventilator-associated pneumonia, pressure ulcers, obstruction of endotracheal tube, unplanned extubation, unplanned removal of central venous catheters or arterial lines, unplanned removal of chest tubes, pneumothorax and cardiac arrest).
      For the assessment of methodologic quality and risk of bias, we abstracted the following data: randomization methods and allocation concealment; number of withdrawals and losses to follow-up after randomization; crossovers between assigned groups; blinding of outcome assessors; and whether the trial was stopped early because of evidence of benefit. We assessed risk of bias using a modified version of the Cochrane risk-of-bias instrument.22 Because blinding of caregivers, patients and family members was not possible in the trials, we determined whether important co-interventions (e.g., weaning, sedation and paralysis) were standardized or applied equally in the treatment and control groups. We assessed the quality of evidence for our primary outcome using the GRADE approach (Grading of Recommendations Assessment, Development and Evaluation).23
      Primary investigators collaborated in this systematic review by confirming original trial data, providing previously unpublished data for subgroups of patients, and clarifying data and methods.

      Data synthesis

      We performed 2 subgroup analyses. First, we hypothesized that maximizing the daily duration of prone positioning would optimize lung protection. We compared trials in which prone positioning was prolonged (≥16 h/d) with those in which the duration was shorter. Second, we hypothesized that prone positioning would be of greater benefit in patients with more severe hypoxemia at baseline. We compared the effect of prone positioning on mortality among patients who had severe hypoxemia (baseline ratio of partial pressure of arterial oxygen to fraction of inspired oxygen [PaO2/FIO2] < 100 mm Hg) with mortality among patients who had moderate hypoxemia (PaO2/FIO2 ratio 100–199 mm Hg) and those who had mild hypoxemia (PaO2/FIO2 ratio 200–299 mm Hg).19
      Finally, we analyzed the effect of prone positioning on oxygenation by obtaining data on the mean PaO2/FIO2 ratios on the first, second and third day after randomization for each treatment group.
      We analyzed all outcomes using the intention-to-treat approach. We aggregated outcomes data at the trial level and performed statistical calculations using Review Manager software (RevMan version 5.1; Nordic Cochrane Centre, Cochrane Collaboration, 2011) and Stata software (Stata Statistical Software, release 9.2; StataCorp, 2006). For the pooled analyses, we used random-effects models, which incorporate between-study variation and generally result in wider confidence intervals than fixed-effects models do when heterogeneity is present. We reported continuous outcomes as ratios of means24 (a measure of relative change) and binary outcomes as risk ratios (RRs). For each subgroup analysis, we tested for interaction between the RR for mortality in each subgroup, which tests the null hypothesis that the treatment effect in each subgroup is the same. All statistical tests were 2-sided. We considered a p value of less than 0.05 to be statistically significant and reported individual trial and summary results with 95% confidence intervals (CIs).
      We assessed between-study heterogeneity for each outcome using the I2statistic.25 We considered statistical heterogeneity to be low if the I2 value was 25%–49%, moderate if 50%–74% and high if 75% or greater.
      We assessed publication bias using the Begg rank correlation test26 and the Peters regression test.27 Given the low power of these tests, we considered a pvalue less than 0.1 to indicate publication bias.

      Results

      Search results and study characteristics

      In addition to the 15 RCTs from the previous meta-analysis,13 we identified 238 potentially eligible reports through searching electronic bibliographic databases. After screening the titles and abstracts and removing duplicate records, we reviewed 22 articles in full. We excluded 11 trials, 6 of which had intervention periods that lasted 48 hours or less,2833 which left 11 trials1417,3440 for the meta-analysis (Figure 1). Reviewers were in total agreement about the included studies.
      Figure 1:
      Selection of randomized controlled trials (RCTs) for the meta-analysis. ARDS = acute respiratory distress syndrome.
      The characteristics of the 11 included trials are summarized in Table 1 and in Appendix 3 (available atwww.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.140081/-/DC1). A total of 2341 patients were enrolled (median 102, range 16–802); children were included in 1 trial (n = 102). Overall, the median PaO2/FIO2 ratio at enrolment was 118 (range 100–326) mm Hg, the median FIO2 was 73% (range 49%–88%), and the median PEEP was 10 (range 7–13) cm H2O. The duration of ARDS before enrolment was less than 72 hours in 8 trials;14,17,3439 2 studies did not limit the duration before enrolment.15,16 One trial included 802 patients with acute hypoxemic respiratory failure, of whom 413 had ARDS. Another included 53 patients with a Glasgow Coma Score of 9 or less, of whom 7 had ARDS. All of the RCTs, except one small study, defined ARDS according to the American–European Consensus Conference definition, with varying thresholds for the PaO2/FIO2 ratio.
      View this table:
      Table 1:
      Characteristics of randomized controlled trials included in the systematic review*
      Prone positioning was used a median of 17 hours per day (range 4–24 h) for 4.6 days (range 4–10 d) and continued until prespecified criteria for clinical improvement were met (9 trials14,16,17,3439) or after a prespecified duration (2 trials15,40). Six trials (n = 1016) mandated protective lung ventilation in both study groups. Six studies14,16,17,34,36,39 permitted “rescue” prone positioning according to prespecified criteria for life-threatening hypoxemia in patients randomly assigned to the supine position. Protocols or guidelines for mechanical ventilation were used in 6 trials.14,17,3538 Five trials used protocols to manage sedation17,34,36,37,40 and weaning from mechanical ventilation.16,17,34,36,37 Five of the 6 RCTs that mandated protective lung ventilation followed patients until discharge from hospital or a minimum of 90 days; the other trial37 followed patients until hospital discharge or 28 days, whichever occurred first.
      The risk of bias was low in 6 trials, high in 2 and unclear in 3 (Table 2). Using GRADE methodology,23 we found that the quality of evidence for the primary outcome of all-cause mortality was high (see Appendices 4 and 5, available atwww.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.140081/-/DC1). All of the RCTs analyzed outcomes by assigned group. Seven studies were ended early because of slow recruitment15,3436,38,39 or on the basis of a stopping rule for futility.37 One trial at high risk of bias did not report mortality.40 For the primary outcome, there was no loss to follow-up in 4 trials.17,35,37,38 In the remaining 6 trials, less than 5% of patients were lost to follow-up (12/802,166/142,36 6/344,14 2/42,34 2/5339 and 7/30415), and the proportion appeared balanced across treatment groups. Crossovers occurred in 8 trials1417,34,36,37,39 (range 4%–32% of all patients), which involved 0%–41% of patients initially assigned to prone positioning and 0%–21% of those assigned to the supine group.
      View this table:
      Table 2:
      Risk-of-bias assessment of the 11 trials included in the meta-analysis*
      There was no evidence of publication bias (p = 0.4 with Begg rank correlation test; p = 0.5 with Peters regression test).

      Effect on mortality

      The 6 RCTs that mandated protective lung ventilation were included in the primary analysis.14,17,34,35,37,38 They all had a low risk of bias except one trial35 (n = 22), which had a high risk of bias because allocation was not concealed. Mortality was reduced with the use of prone positioning (RR 0.74, 95% CI 0.59–0.95; I2 = 29%) compared with use of the supine position alone (Figure 2). Using a random-effects risk-difference model, we estimated that the number needed to treat to save 1 life was 11 (95% CI 6–50). Our findings remained unchanged in several sensitivity analyses that tested alternative assumptions (Table 3). Conversely, there was no effect of prone positioning on mortality in the 4 trials that permitted higher tidal volumes than currently recommended (RR 0.98, 95% CI 0.86–1.12; I2 = 0%), which differed when compared with trials using protective lung ventilation (interaction p = 0.05).
      Figure 2:
      Effect of prone positioning during mechanical ventilation on all-cause mortality among patients with acute respiratory distress syndrome in trials that used protective lung ventilation (tidal volume < 8 mL/kg) and in trials that did not mandate protective ventilation. Risk ratios less than 1.0 indicate a decreased risk of death with prone positioning. *Mortality data differed from the original publication after verification by the primary investigator. The test for subgroup interaction is statistically significant (p = 0.05). CI = confidence interval, RR = risk ratio.
      View this table:
      Table 3:
      Results of primary and sensitivity analyses for the effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome (ARDS)
      A priori subgroup analyses are summarized in Figure 3. All-cause mortality was reduced when the daily duration of prone positioning was prolonged (RR 0.77, 95% CI 0.64–0.92; I2 = 21%) but not when the daily duration was shorter. Only 1 of the 6 trials with a prolonged duration did not use protective lung ventilation.36 Prone positioning reduced all-cause mortality among patients with severe hypoxemia at baseline (RR 0.76, 95% CI 0.61–0.94; I2 = 0%). In the subgroups of patients with mild and moderate hypoxemia, prone positioning did not significantly reduce mortality, and statistical heterogeneity increased in the group with moderate hypoxemia (I2 = 42%). The test for interaction was significant for the analyses according to use of protective lung ventilation and daily duration of prone positioning, but not for the analysis according to degree of hypoxemia.
      Figure 3:
      Effect of prone positioning during mechanical ventilation on all-cause mortality according to prespecified patient-level and trial-level subgroups. Risk ratios less than 1.0 indicate a decreased risk of death with prone positioning. *Severe hypoxemia = ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FIO2) < 100 mm Hg; moderate = PaO2/FIO2 ratio 100–199 mm Hg; mild = PaO2/FIO2 ratio 200–299 mm Hg. CI = 95% confidence interval, RR = risk ratio. Baseline PaO2/FIO2 ratios were unavailable for 10 patients in 3 trials.17,34,35

      Effect on secondary outcomes

      Improvements in oxygenation were greater in the prone group than in the supine group, with PaO2/FIO2 ratios increasing by 25%–36% during the first 3 days after randomization (Table 4). Moderate heterogeneity was detected for the analysis of PaO2/FIO2 ratio on day 1 (I2 = 49%) and day 2 (I2 = 27%), but not on day 3 (I2 = 0%).
      View this table:
      Table 4:
      Physiologic, clinical and safety outcomes associated with prone positioning during mechanical ventilation
      The risk of pressure ulcers, obstruction of the endotracheal tube and dislodgement of the thoracostomy tube was higher among patients placed in the prone position than among those in the supine group. There was no difference in other adverse events between the 2 groups (Table 4).

      Interpretation

      Our analysis of high-quality evidence showed that prone positioning during mechanical ventilation reduces mortality among patients with ARDS receiving protective lung ventilation. The quality of evidence was high, and the number needed to treat to save one life was 11 (95% CI 6–50). Our findings complement those of a recent positive RCT17 and showed consistency of effect across previous RCTs and in the sensitivity analyses.
      Most RCTs of prone positioning during mechanical ventilation in patients with ARDS failed on their own to show statistically significant reductions in mortality despite improvements in oxygenation.15,16,36,39 Previous systematic reviews were similarly unable to show reductions in mortality,4143 although some suggested a mortality benefit among sicker patients.13,42 Limitations of earlier trials, including use of injurious tidal volumes (> 8 mL/kg of predicted body weight), enrolment of patients with mild ARDS,15,16,35,3739 and inadequate duration of prone positioning,15,16,38,39 may have reduced the “signal” and increased “noise.” A recent RCT found a large reduction in mortality among patients with moderate to severe ARDS who were placed in the prone position for 16 hours per day and had protective lung ventilation.17 In our systematic review, we similarly reduced “noise” by limiting the primary analysis to trials mandating low tidal volumes and enrolling patients with moderate to severe ARDS; most trials also used long daily durations of prone positioning, which may have enhanced the “signal.”
      Our finding that prone positioning decreased mortality and improved oxygenation is consistent with results of prior observational and experimental studies,9,30,44 which showed that prone ventilation improves recruitment of collapsed alveoli. Use of the prone position reduced mortality in the subgroup of patients who had severe hypoxemia at baseline (PaO2/FIO2 ratio < 100 mm Hg), with minimal statistical heterogeneity, a finding that is consistent with our previous systematic review.13 However, we found no evidence that the prone position had a differential effect according to severity of hypoxemia, acknowledging the limited number of patients with mild to moderate hypoxemia. Future trials may help to clarify the effects of prone positioning in patients with mild to moderate ARDS.
      Prone positioning during mechanical ventilation is not without risks. Our study showed that patients in the prone group were at increased risk of pressure ulcers, obstruction of the endotracheal tube and dislodgement of the thoracostomy tube. Although there was no significant difference in the occurrence of other complications between the prone and supine groups, these adverse events may occur more frequently in centres with less experienced personnel who use prone positioning infrequently. Furthermore, the perceived risk of prone positioning and the impact on other aspects of critical care such as enteral feeding and sedation4547 may prevent implementation of this manoeuvre in centres that do not frequently care for patients with severe ARDS. The increased risk of certain adverse outcomes underscores the need to have protocols for using prone positioning and to have adequate training and, when these are not available, to consider referring patients to centres with expertise. Future research is needed to address whether referring patients with severe ARDS early to experienced centres for prone positioning or other adjunctive therapies improves their outcomes.48,49

      Limitations

      Although we found high-quality evidence using rigorous methodology, our systematic review has limitations. Several trials were terminated early because of slow enrolment, which reduced statistical power. However, none of the trials was stopped early because of a beneficial effect.50
      The trials were diverse with respect to inclusion criteria, daily duration of prone positioning and use of protocols for other aspects of ventilator management (e.g., weaning and sedation). Trials in which the daily duration of prone positioning was prolonged tended to be recent and overlapped with those that used protective lung ventilation. It was therefore difficult to identify the precise aspect of the patient population or the protocol for prone positioning most responsible for improved survival. Nevertheless, statistical heterogeneity was low for our primary outcome. Five of the 6 trials included in the primary analysis had risk ratios that pointed toward a benefit of prone positioning.
      Several trials reported crossover of patients between the prone and supine groups. We analyzed all outcomes on an intention-to-treat basis, which would have underestimated the effect of prone positioning on mortality.
      Although we searched for RCTs with either an adult or a pediatric study population, we found only one small trial that had enrolled children. An adequately powered RCT would be helpful to confirm our findings in children with ARDS.
      Our findings are based on relatively few trials, some of which enrolled small numbers of patients and accrued few outcome events, which may have reduced precision and underestimated heterogeneity. The duration of follow-up in the included studies was short, and few examined the impact of prone positioning on long-term survival and quality of life.
      Finally, all of the studies included in our primary analysis limited the duration of ARDS before enrolment, which made it difficult to ascertain whether prone positioning was beneficial if started late or as a rescue intervention for patients with life-threatening hypoxemia.

      Conclusion

      Our analysis of high-quality evidence showed that mechanical ventilation in the prone position significantly reduced mortality among patients with ARDS who received protective lung ventilation. This technique was beneficial to patients with moderate to severe ARDS when used for prolonged periods of 16 hours or more each day.

      Footnotes

      • Competing interests: Jordi Mancebo received grants from Covidien and General Electric for research on proportional assist ventilation and functional residual capacity; he served on the data monitoring and safety board for a trial sponsored by Air Liquide, and on the steering committees for Faron Pharmaceuticals and ALung Technologies. Luciano Gattinoni was a member of an advisory board for KCI Medical. No other competing interests were declared.
      • This article has been peer reviewed.
      • Contributors: Sachin Sud had full access to all of the data and takes responsibility for the integrity of the data and the accuracy of the analysis. He contributed to the study concept and design and to the acquisition, analysis and interpretation of data. Claude Guerin, Jan Friedrich and Neill Adhikari contributed to the study concept and design. Jan Friedrich, Neill Adhikari and Maneesh Sud contributed to the acquisition, analysis and interpretation of data. Sachin Sud drafted the manuscript. All of the authors critically revised the manuscript for important intellectual content and approved the final version submitted for publication. All of the authors agreed to act as guarantors of the work.
      • Funding: No specific funding was received for this study. Jan Friedrich is a clinician–scientist of the Canadian Institutes of Health Research (CIHR). Martha Curley’s work was funded by the National Institutes of Health/ National Institute of Nursing Research (NIH/ NINR) (grant no. RO1NR05336).

      References






















































































Nenhum comentário:

Postar um comentário